본문 바로가기
KERD
논문KCI 등재

만성 세균성 전립선염

Chronic Bacterial Prostatitis

박흥재
대한요로생식기감염학회|2014.04|Urogenital Tract Infection|제9권 제1호|pp. 21-26

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

EtiologyProstatitisTherapeutics
주제분류비뇨기과학

초록

Men with prostatitis-like symptoms who had uropathogenic bacteria localized to the prostate gland by elaborate collection and culturing techniques were diagnosed with chronic bacterial prostatitis. Chronic bacterial prostatitis is characterized by prolonged or recurrent symptoms and relapsing bacteriuria. Chronic bacterial prostatitis is caused mainly by Gram-negative uropathogens. For treatment, fluoroquinolones are considered the drug of choice because of their favorable pharmacokinetic properties and antimicrobial spectrum, with the best evidence supporting ciprofloxacin and levofloxacin. Despite conduct of intensive investigations, our knowledge regarding the diagnostic ability to differentiate bacterial from nonbacterial prostatitis, the relevance of nontraditional uropathogens, and the relationship between uropathogens localized to the prostate and recurrent urinary tract infection is still limited. In this paper, we reviewed the new concepts associated with chronic bacterial prostatitis and explored the evolution of our understanding of the etiology, diagnosis, and treatment of this significant urologic disease.

Abstract

Men with prostatitis-like symptoms who had uropathogenic bacteria localized to the prostate gland by elaborate collection and culturing techniques were diagnosed with chronic bacterial prostatitis. Chronic bacterial prostatitis is characterized by prolonged or recurrent symptoms and relapsing bacteriuria. Chronic bacterial prostatitis is caused mainly by Gram-negative uropathogens. For treatment, fluoroquinolones are considered the drug of choice because of their favorable pharmacokinetic properties and antimicrobial spectrum, with the best evidence supporting ciprofloxacin and levofloxacin. Despite conduct of intensive investigations, our knowledge regarding the diagnostic ability to differentiate bacterial from nonbacterial prostatitis, the relevance of nontraditional uropathogens, and the relationship between uropathogens localized to the prostate and recurrent urinary tract infection is still limited. In this paper, we reviewed the new concepts associated with chronic bacterial prostatitis and explored the evolution of our understanding of the etiology, diagnosis, and treatment of this significant urologic disease.

참고문헌 (42)

  1. Woo YN, "Prostatitis", Korean J Urol, 35, pp.575~585 (1994)
  2. Krieger JN, "Epidemiology of prostatitis : new evidence for a world-wide problem", World J Urol, 21, pp.70~74 (2003)
  3. Millán-Rodríguez F, "Acute bacterial prostatitis : two different sub-categories according to a previous manipulation of the lower urinary tract", World J Urol, 24, pp.45~50 (2006)
  4. Nickel JC, "Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index", J Urol, 165, pp.842~845 (2001)
  5. 대한감염학회, "요로 감염 임상진료지침 권고안: 무증상 세균뇨, 단순 요로감염, 복잡성 요로감염, 세균성 전립선염", Infection and Chemotherapy, 43(1), pp.1~25 (2011), 대한감염학회
  6. Nickel JC, "Chronic bacterial prostatitis : an evolving clinical enigma", Urology, 66, pp.2~8 (2005)
  7. Terai A, "Molecular epidemiological evidence for ascending urethral infection in acute bacterial prostatitis", J Urol, 164, pp.1945~1947 (2000)
  8. Kirby RS, "Intra-prostatic urinary reflux : an aetiological factor in abacterial prostatitis", Br J Urol, 54, pp.729~731 (1982)
  9. Lobel B, "Chronic prostatitis: what we know, what we do not know, and what we should do!", World J Urol, 21, pp.57~63 (2003)
  10. Guo H, "Heat-shock protein 70 expression in the seminal plasma of patients with chronic bacterial prostatitis and chronic prostatitis", chronic pelvic pain syndrome, 2010, pp.13, 338~342
  11. Cho YH, "Antibacterial effect of intraprostatic zinc injection in a rat model of chronic bacterial prostatitis", Int J Antimicrob Agents, 19, pp.576~582 (2002)
  12. 김성인, "만성세균성전립선염 흰쥐 모델에서 마늘 추출물의 염증 예방 및 항균, 항염 효과", Investigative and Clinical Urology, 50(6), pp.602~608 (2009), 대한비뇨기과학회
  13. Yoon BI, "Anti-inflammatory and antimicrobial effects of nanocatechin in a chronic bacterial prostatitis rat model", J Infect Chemother, 17, pp.189~194 (2011)
  14. Han CH, "Synergistic effect between lycopene and ciprofloxacin on a chronic bacterial prostatitis rat model", Int J Antimicrob Agents, 31(Suppl 1), pp.S102~S107 (2008)
  15. Nickel JC, "Coagulase-negative staphylococcus in chronic prostatitis", J Urol, 147, pp.398~400 (1992)
  16. Ha US, "Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease", Int J Antimicrob Agents, 31(Suppl 1), pp.S96~S101 (2008)
  17. Ruiz J, "Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men", J Clin Microbiol, 40, pp.4445~4449 (2002)
  18. Johnson JR, "Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis", J Infect Dis, 191, pp.46~50 (2005)
  19. Nickel JC, "Bacterial localization in antibioticrefractory chronic bacterial prostatitis", Prostate, 23, pp.107~114 (1993)
  20. Nickel JC, "Bacterial biofilms: influence on the pathogenesis, diagnosis and treatment of urinary tract infections", J Antimicrob Chemother, 33(Suppl A), pp.31~41 (1994)
  21. Soto SM, "Biofilm formation in uropathogenic Escherichia coli strains : relationship with prostatitis, urovirulence factors and antimicrobial resistance", J Urol, 177, pp.365~368 (2007)
  22. Mazzoli S, "Biofilms in chronic bacterial prostatitis(NIH-II)and in prostatic calcifications", FEMS Immunol Med Microbiol, 59, pp.337~344 (2010)
  23. Bundrick W, "Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis : a randomized double-blind multicenter study", Urology, 62, pp.537~541 (2003)
  24. Nickel JC, "Leukocytes and bacteria in men with chronic prostatitis", chronic pelvic pain syndrome compared to asymptomatic controls, 2003, pp.170, 818~822
  25. Nickel JC, "Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis", J Urol, 179, pp.1391~1395 (2008)
  26. Krieger JN, "Inconsistent localization of gram-positive bacteria to prostate-specific specimens from patients with chronic prostatitis", Urology, 66, pp.721~725 (2005)
  27. Shurbaji MS, "Immunohistochemical demonstration of Chlamydial antigens in association with prostatitis", Mod Pathol, 1, pp.348~351 (1988)
  28. Ohkawa M, "Ureaplasma urealyticum in the urogenital tract of patients with chronic prostatitis or related symptomatology", Br J Urol, 72, pp.918~921 (1993)
  29. Potts JM, "Association of ureaplasma urealyticum with abnormal reactive oxygen species levels and absence of leukocytospermia", J Urol, 163, pp.1775~1778 (2000)
  30. Krieger JN, "Prostatitis : what is the role of infection", Int J Antimicrob Agents, 19, pp.475~479 (2002)
  31. Weidner W, "The role of Chlamydia trachomatis in prostatitis", Int J Antimicrob Agents, 19, pp.466~470 (2002)
  32. Goto T, "Bacterial biofilms and catheters in experimental urinary tract infection", Int J Antimicrob Agents, 11, pp.227~231 (1999)
  33. Lipsky BA, "Treatment of bacterial prostatitis", Clin Infect Dis, 50, pp.1641~1652 (2010)
  34. Naber KG, "Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis", Int J Antimicrob Agents, 32, pp.145~153 (2008)
  35. Naber KG, "Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis", Int J Antimicrob Agents, 20, pp.18~27 (2002)
  36. Skerk V, "Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis", J Chemother, 14, pp.384~389 (2002)
  37. Skerk V, "Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis", Int J Antimicrob Agents, 21, pp.457~462 (2003)
  38. Skerk V, "Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis", Int J Antimicrob Agents, 24, pp.188~191 (2004)
  39. Kolumbić Lakos A, "A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis : a prospective non-comparative pilot study", J Chemother, 23, pp.350~353 (2011)
  40. 이길호, "Ciprofloxacin Resistance in Enterococcus faecalis Strains Isolated From Male Patients With Complicated Urinary Tract Infection", Investigative and Clinical Urology, 54(6), pp.388~393 (2013), 대한비뇨기과학회
  41. 이승주, "급성단순성방광염 여성 환자에서 분리된 요로감염균에 대한 Tosufloxacin과 Ofloxacin, Levofloxacin의 항균력 비교", Infection and Chemotherapy, 39(4), pp.202~207 (2007), 대한감염학회
  42. Yoon BI, "Acute bacterial prostatitis: how to prevent and manage chronic infection?", J Infect Chemother, 18, pp.444~450 (2012)

관련 논문AI추천

급성세균성전립선염의 임상적 특징 및 치료 결과배웅진, 이승주, 조수연, 조용현대한감염학회 · Infection and Chemotherapy2009 · 제41권 제1호급성 세균성 전립선염에서 만성 염증으로의 진행과 관련된 인자의 고찰김설, 손동완, 신태성, 윤병일, 조용현, 하유신대한요로생식기감염학회 · Urogenital Tract Infection2011 · 제6권 제2호급성 세균성 전립선염에 대한 최신 지견손환철, 최우석대한요로생식기감염학회 · Urogenital Tract Infection2011 · 제6권 제1호급성 세균성 전립선염조용현, 하유신대한요로생식기감염학회 · Urogenital Tract Infection2011 · 제6권 제2호한국인의 급성 세균성 전립선염의 특성박승철대한요로생식기감염학회 · Urogenital Tract Infection2013 · 제8권 제1호급성 세균성 전립선염의 임상경과에 관한 다기관 연구구진모, 김준모, 김철성, 김태형, 나용길, 민권식, 서영진, 심봉석, 양상국, 이길호, 이상돈, 이선주, 이성주, 이성호, 정승일, 정재민, 정희종, 조용현, 조원열, 최종보, 한창희대한요로생식기감염학회 · Urogenital Tract Infection2011 · 제6권 제2호

이 간행물의 다른 논문 (10건)

재발성 요로감염에 대한 예방적 항생제 요법박민구, 조대연pp. 1-8재발성 요로감염에 대한 비항생제 예방요법김기호pp. 9-13전립선수술에 대한 예방적 항생제요법정승일pp. 14-20Modulation of Antimicrobial Peptide Human β-defensin-3 by Toll-like Receptor Ligands in Vaginal Epithelial Cells명순철, 김해종, 문영태, 장인호, 김경도, 한준현, 이소연pp. 27-33방광요관역류 소아에서 내시경 수술 후 요로감염의 빈도 및 위험인자구자윤, 박부경, 이상돈pp. 34-38
원문 보기